Latest News

Positive Trial Results For AstraZeneca’s Precision Drug Dato-DXd In Breast Cancer – BusinessToday


share this article!

AstraZeneca said on Friday its experimental precision drug had slowed the progression of a common type of breast cancer in a late-stage trial, a boost for the company after its shares fell in July on results from a separate trial of the same drug for lung cancer. The drug, datopotamab…

Read More

share this article!

NIMP 2030, 12MP MTR; RAM Says Moonshot Aspiration Boils Down To Execution

Previous article

Almost 2 Billion Suspicious Calls, 581 Million SMS Successfully Blocked: Fahmi – BusinessToday

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News